ACTRN12616000742471
Completed
未知
Randomised controlled trial on the effect of long- term sound therapy using predictable and unpredictable sounds in adults with constant tinnitus
Mithila Durai0 sites25 target enrollmentJune 6, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Tinnitus
- Sponsor
- Mithila Durai
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adults aged between 18\-65 years residing in the Auckland region with constant tinnitus and a minimum score of 38 on Tinnitus Functional Index (TFI), normal middle ear function and at maximum a moderate degree of hearing loss (less than 70 dB on average across frequencies).
Exclusion Criteria
- •\- Age is younger than 18 or over 65
- •\- Do not experience constant tinnitus
- •\- Presence of middle ear pathology at the time of testing (e.g. glue ear)
- •\- Presence of a hearing loss greater than moderately severe (greater than 70 dB on average across frequencies).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Randomized controlled trial of effects of long-term consumption of milk and dairy products in addition to dietary guidance on metabolic syndromeMetabolic SyndromeJPRN-UMIN000006353Japan Dairy Association200
Active, not recruiting
Phase 1
Randomized controlled trial in patients on long-term colchicine with colchicine-resistant familial Mediterranean fever (FMF) to evaluate the efficacy of on-demand Anakinra treatment for painful attacks in patients who refuse continuous daily therapy (KIN-ATTACK-FMF).Familial Mediterranean Fever (FMF)MedDRA version: 20.0Level: SOCClassification code: 10010331Term: Congenital familial and genetic disorders Class: 21Therapeutic area: Diseases [C] - Immune System Diseases [C20]CTIS2023-506721-11-00Assistance Publique Hopitaux De Paris50
Completed
Phase 3
REGiM: Prolonged treatment with darbepoetin alpha (EPO), with/without recombinant human granulocyte colony stimulating factor (G-CSF), versus best supportive care in patients with low-risk myelodysplastic syndromes (MDS)Topic: National Cancer Research NetworkSubtopic: Haematological OncologyDisease: Leukaemia (acute myeloid)CancerMyelodysplastic syndromesISRCTN65652441Barts and The London NHS Trust (UK)1,200
Completed
Not Applicable
Randomized-controlled trial for an effect of a long-term micronutrients supplement on endothelial function.Endothelial dysfunctionJPRN-UMIN000004436Public Health, Graduate school of Medicine, Osaka University127
Completed
Not Applicable
Randomized controlled clinical study on the Long-term success of implants and the prosthetic supply for rehabilkitation of single-tooth gaps in postertior tooth regions depending on the material selection for hybridabutment crowns.K08.1Loss of teeth due to accident, extraction or local periodontal diseaseDRKS00009628niversitätsklinikum Ulm/Studienleiter: Prof. Dr. Ralph G. Luthardt, Klinik für Zahnärztliche Prothetik60